If you or a loved one were prescribed and took Xeljanz and then suffered from blood clots, you may be entitled to substantial compensation. Contact the Kishish Law Group today for your free and confidential case evaluation by calling us toll free at 1 (888) 609-4664 or by completing our contact form.
The U.S. Food and Drug Administration has warned that certain doses of Xeljanz can increase the likelihood of blood clots in the lungs. These clots can be life-threatening—one in three people that have an undiagnosed and untreated clot do not survive.
Affected patients and their families are now suing Pfizer, the manufacturer of Xeljanz, accusing the pharmaceutical company of failing to warn patients and doctors about the dangerous side effects associated with the drug. Participating in a Xeljanz lawsuit can help you pay for medical bills, lost wages, and other costs associated with suffering due to taking Xeljanz. Additionally, these lawsuits can help send a message to the big pharmaceutical companies that they should comprehensively test their drugs for safety before releasing them on the market.
What is Xeljanz?
Xeljanz (tofacitinib) is a drug commonly prescribed to treat rheumatoid arthritis and ulcerative colitis. Xeljanz was initially approved by the FDA to treat rheumatoid arthritis in 2012. The FDA later approved the drug to treat psoriatic arthritis and ulcerative colitis. Xeljanz is a janus kinase inhibitor; it works by inhibiting the activation of an inflammation pathway in the body. By dampening the body's natural inflammation pathway, Xeljanz can help prevent damage to the joints or bowels of patients associated with rheumatoid arthritis and ulcerative colitis, both of which are worsened by inflammation.
Pfizer, the manufacturer of Xeljanz, has made hundreds of millions of dollars off sales of the drug.
What are the side effects of Xeljanz?
Though Pfizer has disclosed several side effects of taking Xeljanz, the FDA has recently warned that Xeljanz may increase the risk of blood clots at certain doses, a previously undisclosed side effect. The FDA says that patients taking Xeljanz or Xeljanz XR should seek medical attention immediately if they experience any of the following symptoms, as these symptoms may indicate the presence of a blood clot:
- Shortness of breath or difficulty breathing
- Pain in the chest or back
- Coughing up blood
- Excessive sweating
- Clammy or bluish colored skin
Blood clots can cause conditions like pulmonary embolism, deep vein thrombosis (DVT), strokes, or other blood clot-related injuries, many of which may be life threatening. Nevertheless, patients currently taking Xeljanz should not stop taking the medication without consulting a medical professional as doing so could worsen their condition.
Medical agencies continue to evaluate the drug for safety to determine the extent of the risk of blood clots. As a part of its approval of the drug, the FDA is requiring Pfizer to perform further studies of Xeljanz and its capacity to cause blood clots. The European Medical Agency has also placed the drug under evaluation, requesting that doctors not prescribe the drug anymore until studies of the risks of blood clots are complete.
What do the Xeljanz lawsuits say?
Plaintiffs accuse the manufacturer of Xeljanz of failing to warn patients about the dangerous side effects of the drug. Plaintiffs say that Pfizer knew or should have known that Xeljanz was more dangerous than advertised and should have warned patients about the increased risk of blood clots associated with the drug. Had Pfizer fully disclosed the risks of taking Xeljanz, patients might have chosen a different drug or forwent treatment with the drug entirely.
Do I have a Xeljanz lawsuit?
Contacting a lawyer is the best way to determine whether you have a Xeljanz lawsuit. An experienced legal professional is in the best position to help secure your maximum recovery. The Kishish Law Group can help. Our lawyers and staff will listen to your story and assist you in finding your legal path forward. If you or a loved one were prescribed and took Xeljanz and then suffered blood clots or a pulmonary embolism, contact the Kishish Law Group today to discuss your legal options. Waiting too long may prevent you from recovering at all on your Xeljanz claim.
DISCLAIMER: No attorney client relationship will exist between you and our firm until we enter into a signed Retainer/Services Agreement. Completion of this document is for informational purposes only and does not constitute a Retainer/Services Agreement. The information you obtain at this site is not, nor is it intended to be, legal advice. Contacting us does not create an attorney-client relationship. In some jurisdictions this website may be considered lawyer advertising. You should consult an attorney for advice regarding your individual situation. Click here for more information.
Speak with a Xeljanz Blood Clots Lawyer
If you were prescribed and took Xeljanz and then suffered from blood clots, you may be entitled to compensation.
Reach out to Kishish Law Group immediately to find out your legal options.
- April 1, 2020
FDA Requests Companies to Stop Selling All Zantac Products, Citing Cancer Concerns
- August 13, 2018
FDA Updates List of Valsartan Blood Pressure Medication Affected by Recall
- February 18, 2018
Invokana Lawsuits Rise, First Trial of Alleged Amputation Set for September
- June 12, 2017
Invokana Side Effects and Diabetic Ketoacidosis
- June 8, 2017
SGLT2 Inhibitors, like Invokana, Found to Double Risk of Diabetic Ketoacidosis